The retinoblastoma protein (pRB) and the pRB-related p107 and p130 comprise the 'pocket protein' family of cell cycle regulators. These proteins are best known for their roles in restraining the G1-S transition through the regulation of E2F-responsive genes. pRB and the p107/ p130 pair are required for the repression of distinct sets of genes, potentially due to their selective interactions with E2Fs that are engaged at specific promoter elements. In addition to regulating E2F-responsive genes in a reversible manner, pocket proteins contribute to silencing of such genes in cells that are undergoing senescence or differentiation. Pocket proteins also affect the G1-S transition through E2F-independent mechanisms, such as by inhibiting Cdk2 or by stabilizing p27 Kip1 , and they are implicated in the control of G0 exit, the spatial organization of replication, and genomic rereplication. New insights into pocket protein regulation have also been obtained. Kinases previously thought to be crucial to pocket protein phosphorylation have been shown to be redundant, and new modes of phosphorylation and dephosphorylation have been identified. Despite these advances, much remains to be learned about the pocket proteins, particularly with regard to their developmental and tumor suppressor functions. Thus continues the story of the pocket proteins and the cell cycle. Oncogene (2005 Oncogene ( ) 24, 2796 Oncogene ( -2809 Oncogene ( . doi:10.1038 Keywords: pocket proteins; pRB; p107; p130; E2F; cell cycle More than 50 yeas ago, a children's tumor was realized to occur sporadically in some patients, but to be inherited in others (Falls and Neel, 1951) . The tumor was retinoblastoma, and although it was quite rare, its uncommon genetics offered a handle with which to grasp the cause of one form of human cancer. It was hypothesized that retinoblastomas begin as a result of two mutations, or 'hits' (Knudson, 1971) , which were later surmized to disable the two alleles of a tumor suppressor gene (Cavenee et al., 1983) . The cloning of the retinoblastoma (RB) gene (Friend et al., 1986) and the identification of biallelic RB mutations in retinoblastoma tumors (Dunn et al., 1988) supported the two hit hypothesis and validated the tumor suppressor gene concept.
While the cloning of RB concluded the search for the retinoblastoma suppressor, it opened a new chapter in cancer biology focusing on the new gene's function. Unexpectedly, RB was found to be mutated in many additional cancers (Harbour et al., 1988; Lee et al., 1988; Horowitz et al., 1989) , and its encoded protein, pRB, was widely expressed and regulated in a manner consistent with its having a general cell cycle role (Lee et al., 1987; Buchkovich et al., 1989; DeCaprio et al., 1989 ; reviewed in Cobrinik et al., 1992) . Additional studies revealed that pRB acted together with two related proteins, p107 and p130, to regulate proliferation in most if not all cell types (Cobrinik, 1996; Dyson, 1998; Nevins, 1998) . It is now evident that pRB, p107, and p130, together known as the 'pocket proteins,' are central participants in a gene regulatory network that governs the cellular response to antimitogenic signals, and whose deregulation constitutes one of the hallmarks of cancer (Hanahan and Weinberg, 2000) .
Pocket proteins, E2Fs, and the G1-S transition
Many aspects of pRB's cell cycle function were outlined about 10 years ago (Weinberg, 1995) . By then, pRB was known to be a nuclear protein that is minimally (or hypo-) phosphorylated in resting or G0 cells, to be increasingly phosphorylated during progression through G1, and to be maintained in a hyperphosphorylated state until late in mitosis (Figure 1 ). pRB phosphorylation was recognized to be directed by mitogenic signals that converge on the cell cycle machinery, composed of D cyclins acting with Cdk4 or Cdk6 in early and mid-G1, and composed of E cyclins acting with Cdk2 in late G1. Hypophosphorylated pRB was further recognized to inhibit proliferation through its association with other proteins. A principal target appeared to be the E2F transcription factor, which was known to regulate proliferation-associated genes (Nevins, 1992) .
Early studies suggested that hypophosphorylated pRB binds and inhibits the E2F transactivation domain, and that pRB phosphorylation releases E2F to allow the expression of genes that mediate S phase entry (Flemington et al., 1993; Helin et al., 1993) . This model illustrated how loss or mutation of RB leads to deregulation of E2F and inappropriate proliferation. It also illustrated how other oncogenic insults deregulate E2F through their effects on pRB (Figure 1 ). For example, this could be accomplished by DNA tumor virus proteins that bind to pRB and displace E2F, or by inappropriate pRB phosphorylation due to overexpression of D cyclins, loss of the p16 INK4A inhibitor of Cdk4 and Cdk6, or mutation or amplification of the Cdk4 or Cdk6 genes (Weinberg, 1995; Sherr, 1996) . While this model remains useful for conceptualizing pRB's core cell cycle function, we now understand the pRB-E2F pathway to be far more elaborate.
A fundamental addition to the early model came with the recognition that pRB and E2F are members of protein families, consisting of the pRB, p107, and p130 pocket proteins, E2F1-7, and the DP1 and DP2-binding partners of E2F1-6 (Cobrinik, 1996; Dyson, 1998; Nevins, 1998; Dimova and Dyson, 2005) . In addition, it was realized that pocket proteins not only inhibit E2F-mediated transactivation but also function together with E2Fs to actively repress transcription and inhibit G1-S progression (Zhang et al., 1999; He et al., 2000) . Moreover, the ectopic expression of E2F-responsive genes such as cyclin E1, cyclin A2, and Emi1 (which stabilizes cyclin A) was found to overcome pocket protein-dependent G0/G1 arrests (Alevizopoulos et al., 1997; Leng et al., 1997; Lukas et al., 1997; Hsu et al., 2002) . This demonstrated that pocket protein-mediated repression of such genes is important for inhibiting the G1-S transition.
More recently, pocket proteins and E2Fs were found to govern the expression of a far wider network of genes than those controlling S phase entry and progression. Specifically, they also regulate genes that control entry into and progression through mitosis, and they coordinate these cell cycle programs with transcriptional programs mediating checkpoint control, the DNA damage response, apoptosis, differentiation, and development (Ishida et al., 2001; Muller et al., 2001; Polager et al., 2002; Ren et al., 2002; Weinmann et al., 2002; Dimova et al., 2003) . Thus, the deregulation of E2Fs has far wider consequences than simply increased proliferation, and may also account for the propensity of tumor cells to undergo apoptosis, to have checkpoint defects, to have an altered DNA damage response, and to resist the effects of differentiation agents.
The expanding influence of the pocket protein-E2F network has been the subject of several recent reviews (Cam and Dynlacht, 2003; Blais and Dynlacht, 2004; Bracken et al., 2004; Liu et al., 2004; Dimova and Dyson, 2005) , and is not further detailed here. Instead, this review focuses on mechanisms through which specific pocket proteins regulate different E2F-responsive genes, particularly the cyclin E1 and cyclin A2 (hereafter, 'cyclin E' and 'cyclin A') effectors of the G1-S transition. E2F-independent functions of pocket proteins, roles of pocket proteins in other cell cycle transitions, new means of pocket protein regulation, and the partially redundant behaviors of pocket proteins in cell cycle control and development are also discussed.
A dynamic pocket protein-E2F network
In mammalian cells, the pocket protein and E2F families can be divided into subgroups whose members have similar functions (Figure 2 ). Among the pocket proteins, p107 and p130 are more related to one another than either is related to pRB, in terms of both their structure and their function (Classon and Dyson, 2001) . Like pRB, the p107 and p130 proteins bind E2Fs, and their phosphorylation by G1 cyclins and Cdks results in E2F dissociation. However, p107 and p130 preferentially bind different E2Fs from those bound by pRB, and are required for the regulation of distinct E2F-responsive genes. Moreover, whereas pRB is commonly expressed in both proliferating and nonproliferating cells, p107 is most prominent in proliferating cells and p130 is most prominent in arrested cells (Classon and Dyson, 2001) .
Among the E2F family, E2F1, E2F2, and E2F3a are strong transcriptional activators that are preferentially bound and inhibited by pRB (Figure 2 ). E2F1-3a are generally absent or expressed at low levels in quiescent cells, and are induced to high levels and stimulate gene expression in late G1 (Dyson, 1998) . A distinct E2F3b isoform is expressed throughout the cell cycle, and is implicated in forming transcriptional repressor complexes with Rb in G0 (Leone et al., 2000) , and in 
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Figure 1 A simplified view of the pRB-E2F pathway. In this rendition, pRB binds and inhibits E2F in G0 and early G1. In proliferating cells, pRB phosphorylation by cyclin D-Cdk4/Cdk6 releases E2F, which then induces genes that mediate S phase entry. In tumor cells, the pRB-E2F interaction is disrupted by mutation of the RB gene (X), by pRB binding to DNA tumor virus oncoproteins such as human papilloma virus E7, or by inappropriate pRB phosphorylation due to overexpression of D cyclins, loss of the p16 INK4A inhibitor of Cdk4/Cdk6, or mutation or overexpression of the Cdk4 or Cdk6 genes Pocket proteins and cell cycle control D Cobrinik forming pocket protein-independent repressor complexes in both resting and normally proliferating cells (Aslanian et al., 2004; Ginsberg, 2004) . In contrast, E2F4 and the generally less abundant E2F5 are poor transcriptional activators, in part owing to their lack of a nuclear localization signal. E2F4 and 5 are expressed throughout the cell cycle, but in G0 and early G1 they are bound and recruited to the nucleus by p107 and p130, and form transcriptional repressor complexes. Two other family members, E2F6 and E2F7, do not bind pocket proteins, and repress E2F-responsive genes through other means (Dimova and Dyson, 2005) .
As noted above, pocket proteins appear to mediate G0/G1 cell cycle arrest through their repression of E2F-regulated genes. They are believed to accomplish this by recruiting a variety of chromatin-modifying activities to E2F-responsive promoters (Frolov and Dyson, 2004) . For example, chromatin immunoprecipitation (ChIP) analyses demonstrated that pocket proteins recruit type I histone deacetylases (HDACs), resulting in removal of acetyl groups from histones H3 and H4 and in a compacted chromatin structure that is refractory to transcription initiation (Takahashi et al., 2000; Ferreira et al., 2001; Morrison et al., 2002; Rayman et al., 2002) . The recruitment of HDACs is indirect (Lai et al., 2001) and accompanied by recruitment of other corepressors, chromatin remodeling factors, and histone methyltransferases (Frolov and Dyson, 2004) . Pocket proteins may also repress transcription through HDAC-independent mechanisms, both in Drosophila (Taylor-Harding et al., 2004) and in mammalian cells (Strobeck et al., 2000; Zhang et al., 2000) , as discussed for cyclin A below. ChIP analyses further showed that in late G1, pocket protein repressor complexes dissociate from E2F-responsive promoters, whereas activating E2Fs bind such promoters and restore histone acetylation (Takahashi et al., 2000; Rayman et al., 2002; Taubert et al., 2004) .
The specific interactions of E2Fs and pocket proteins, together with their distinct expression, subcellular localization, and promoter-binding patterns (as defined by ChIP analyses), have suggested several related models of the pocket protein-E2F network (Stevaux and Dyson, 2002; Trimarchi and Lees, 2002; Cam and Dynlacht, 2003; Bracken et al., 2004) . The models provide for several different states of E2F-responsive promoters in the different cell cycle phases (Figure 3 ). Thus, in G0 and early G1 ( Figure 3A 1 ), p107 and p130 form repressor complexes in conjunction with E2F4 or E2F5 at most if not all E2F-responsive promoters. Meanwhile, pRB is thought to bind E2F1-3 either at, or sequestered away from, such promoters. A third arrangement may involve binding of E2F6 together with polycomb group and other repressor proteins ( Figure 3A 2 ) (Ogawa et al., 2002) . In late G1 ( Figure 3B ), pocket proteins are generally phosphorylated and dissociate from E2Fs. E2F4 and 5 then relocate to the cytoplasm, and the promoters generally bind E2F1-3. Interestingly, at some promoters, E2F1-3 may bind to sites different from those vacated by E2F4 and 5 (Araki et al., 2003; Zhu et al., 2004) . For many promoters, the binding of E2F1-3 correlates with recruitment of histone acetyltransferases (HATs), increased histone acetylation, and transcriptional activation ( Figure 3B 1 ) (Takahashi et al., 2000; Rayman et al., 2002; Taubert et al., 2004) . However, expression of genes such as cyclin A2, cdc2, and cyclin B1 is delayed, and may require the subsequent binding of other transcription factors, such as B-myb ( Figure 3B 2 and C 4 ) . After entry into S phase, E2F1-3 continue to bind and probably activate many promoters ( Figure 3C 1 ) . However, E2F1-3 bind other promoters only until the G1-S transition. These promoters may then be activated by other factors, as in the case of the B-myb gene ( Figure 3C 2 ) (Takahashi et al., 2000) , or may be bound and repressed by E2F7, as for Cdc6 and E2F1 ( Figure 3C 3 ) (Di Stefano et al., 2003) . States or timing other than those displayed in Figure 3 are also possible (Pediconi et al., 2003; Aslanian et al., 2004) , and the situation is further embellished by transcription factors that bind to promoters in cooperation with specific E2Fs or pocket proteins (Karlseder et al., 1996; Lin et al., 1996; Le Cam et al., 1999; Chen et al., 2002; Schlisio et al., 2002; Giangrande et al., 2004; Zhu et al., 2004) . The various contemporaneous states of different E2F-responsive promoters may confer individualized regulation of promoter activity.
An important unresolved aspect of this system is whether E2F1-3 and pRB participate in promoter repression in G0 and early G1. In ChIP analyses Activator E2Fs
Repressor E2Fs Figure 2 Interactions among pocket proteins and E2F transcription factors. Pocket proteins can be subdivided into the pRB and p107/p130 groups. pRB preferentially binds to the activator E2Fs, E2F1, E2F2, and E2F3a; as well as to E2F3b, which may function mainly as a repressor. p107 and p130 preferentially bind the repressor E2Fs, E2F4 and E2F5. E2F6 and E2F7 form transcriptional repressor complexes but do not bind pocket proteins. The DP1 and DP2 proteins form heterodimers with E2F1-6 to allow binding to DNA (not shown), whereas E2F7 binds as a homodimer
Pocket proteins and cell cycle control D Cobrinik of mitogen-deprived cells, all cell cycle-regulated E2F-responsive promoters examined to date bound E2F4 and either p107 or p130. However, relatively few promoters detectably bound E2F1-3 or pRB, and, with the exception of cyclin E, this binding seemed to occur at low levels (Takahashi et al., 2000; Wells et al., 2000; Morrison et al., 2002; Rayman et al., 2002) . These findings are consistent with the notion that pRB directly participates in the repression of only a limited set of E2F-responsive genes in G0 and early G1 cells.
Roles for specific pocket proteins in the regulation of E2F-responsive genes
As shown in Figure 3 , E2F-responsive genes are generally regulated in G0/G1 through the sequestration of activating E2Fs by pRB, and through formation of repressor complexes by p107 and p130. However, this arrangement does not result in redundant control of E2F-responsive genes by pRB and the p107/p130 pair. Indeed, many -and possibly most -E2F-responsive genes are deregulated in p107/p130-deficient cells (Hurford et al., 1997; Mulligan et al., 1998; Ren et al., 2002) . A distinct set consisting of cyclin E and p107 was deregulated in pRB-deficient cells in one study (Hurford et al., 1997) , whereas overlapping sets of genes were deregulated in pRB-deficient versus p107/p130-deficient cells in a more recent report (Black et al., 2003) . The basis for this discrepancy is unclear, although subtle differences in the growth arrest regimens, and hence differences in the G0 states, may be responsible. Interestingly, despite the overlap in pRB-and p107/ p130-regulated genes in the Black et al. (2003) study, a gene expression set that was characteristic of pRBdeficient fibroblasts was also characteristic of pRBdeficient pituitary and thyroid tumor cells, suggesting Other promoters, such as cyclin A2, cdc2, and cyclin B1, bound E2F1-3 in late G1 but were not active until S or G2 Zhu et al., 2004) . (c) S and G2: Among promoters that were active in late G1, some continue to bind E2F1-3 and HATs (C 1 ); others no longer bind E2F1-3 but may be activated by other transcription factors (TFs) (C 2 ); and others are bound and repressed by E2F7 (C 3 ) (Takahashi et al., 2000; Di Stefano et al., 2003) . E2F-responsive promoters that bound E2F1-3 but were inactive in late G1 may be induced through the appearance of other transcription factors, such as B-myb, in the case of cdc2 and CyclinB1 (C 4 ) Pocket proteins and cell cycle control D Cobrinik that pRB has similar transcriptional effects in diverse cell types. Currently, the features that dictate whether a promoter is deregulated by loss of pRB, or by the loss of p107/p130, have not been defined. Clearly, the loss of E2F4-p107/p130 repressor complexes contributes to the deregulation of E2F-responsive promoters in p107/p130-deficient cells (Stevaux and Dyson, 2002; Cam and Dynlacht, 2003) . However, it is less clear why E2F4-pRB repressor complexes, which are often detected in vitro, fail to regulate such promoters in place of the p107/p130 repressor complexes in vivo. Indirect evidence suggests that E2F4-pRB complexes may have low affinity for E2F-responsive promoters, since sites that bound E2F4-p130-HDAC1 complexes in wild-type cells failed to bind E2F4, pRB, or HDAC1 in p107/p130-deficient cells .
In some cases, a specific pocket protein may be needed to regulate a promoter due to its selective recruitment by other transcription factors. For example, p107 was found to mediate the TGFb-induced repression of cMyc due to its recruitment by Smad3 . Here, the involvement of p107 was dictated by a bipartite Smad-E2F promoter element, by the specific binding of Smad3 to E2F4, and by the specific binding of both Smad3 and E2F4 to p107. p107 or p130 might be recruited to other E2F-responsive promoters in a similar way, particularly in light of evidence that E2F4 often binds to promoters in cooperation with other transcription factors (Le Cam et al., 1999; Araki et al., 2003; Zhu et al., 2004) .
A crucial role for pRB in the regulation of cyclin E The above illustrates how many promoters may be deregulated due to the loss of E2F4-p107/p130 repressor complexes. However, it is less evident how the cyclin E and p107 promoters are deregulated due to the loss of pRB, despite that they, too, bind E2F4-p107/p130 complexes. Nevertheless, recent analyses have provided clues to the role of pRB in the regulation of cyclin E, which is arguably one of the more crucial E2F-responsive genes. Cyclin E is normally expressed only in late G1, is correctly regulated in p107/p130 deficient cells, but is derepressed in G0 and early G1 in pRBdeficient cells (Herrera et al., 1996; Hurford et al., 1997) .
The periodic expression of cyclin E depends upon two E2F elements located within 40 base pairs of the major transcription start site (Figure 4) . One of these, termed CERM, is necessary for repression of cyclin E in G0 and early G1. CERM consists of a variant E2F-binding site and an AT-rich region, and cooperatively binds E2F4 (or 5) and an unidentified AT-rich DNA-binding protein (Le Cam et al., 1999) . E2F4 (or 5) binds to CERM as part of a complex termed CERC, which includes p107 or p130, an HDAC activity, and other proteins. Upon p107 and p130 phosphorylation in late G1, CERM is vacated coinciding with promoter activation. In p107/p130-deficient cells, pRB can substitute for p107/p130 in the CERC to maintain repression in G0 and early G1 (Le Cam et al., 1999; Polanowska et al., 2001; Fabbrizio et al., 2002) .
A second element that regulates cyclin E is a bipartite 'E2F-Sp1' site. This element is crucial to cyclin E expression and is constitutively occupied during the cell cycle (Botz et al., 1996; Le Cam et al., 1999) . Because Sp1 binds E2F1-3, but not E2F4 or 5 (Karlseder et al., 1996) , this element may cooperatively bind Sp1 (or a related protein) and E2F1-3, and may thereby attract pRB in G0 and early G1 cells. ChIP analyses support this idea, as E2F1-3 and pRB were readily detected at the cyclin E promoter (Wells et al., 2000; Morrison et al., 2002) . ChIP assays
Late G 1 Figure 4 Model for pRB-dependent repression of cyclin E. The repression of cyclin E in G0 and early G1 is mediated by a site termed 'CERM,' which binds an AT-rich DNA-binding protein, E2F4 or 5, p130 or p107, and other proteins that together constitute the CERC. A second regulatory site, termed the 'E2F-Sp1' element, is required for cyclin E expression and may cooperatively bind Sp1 (or a related protein) and E2F1-3, and thereby attract pRB and associated repressor proteins (Le Cam et al., 1999; Nielsen et al., 2001; Polanowska et al., 2001; Fabbrizio et al., 2002; Morrison et al., 2002) . pRB can substitute for p107/p130 in the CERC, and may there by maintain normal regulation in p107/p130-deficient cells (Le Cam et al., 1999) . In contrast, it is suggested that p107 and p130 might not substitute for pRB at the E2F-Sp1 element (except under unusual circumstances, Lee et al., 2002) , leading to E2F derepression in pRB-deficient as well as in E2F1-3-deficient cells ( further showed that pRB is required for the recruitment of HDAC1 as well as for histone deacetylation within the cyclin E transcription initiation region (Morrison et al., 2002) . Whereas pRB is expected to dissociate from the cyclin E promoter when phosphorylated in late G1, the E2F-Sp1 element was found to remain occupied and to be crucial to transcriptional activation (Botz et al., 1996; Le Cam et al., 1999) , suggesting that activating E2Fs remain. Interestingly, pRB-mediated histone deacetylation may prepare the cyclin E promoter for additional modifications. For example, pRB also recruits the SUV39H1 histone H3 methyltransferase (or a related methyltransferase), promotes methylation of histone H3 lysine 9 (H3K9), and attracts the repressor protein, HP1 (Nielsen et al., 2001) . However, it is currently unclear whether pRB promotes H3K9 methylation of the cyclin E promoter in a reversible G0 state (quiescence), or does so only in cells that have undergone permanent cell cycle exit (see 'Pocket proteins and silencing of E2F-responsive genes,' below).
Together, the above observations imply that pRB mediates the cyclical repression of cyclin E due to its recruitment of HDACs and potentially histone methyltransferases. However, since p107 and p130 can also bind and recruit such proteins Rayman et al., 2002; Nicolas et al., 2003) , these functions alone seem unlikely to underlie pRB's special role in cyclin E repression. Several lines of evidence suggest that pRB may be crucial to this repression due to the cooperative binding of E2F1-3 and Sp1 (or a related protein) to this promoter, and the need for pRB to bind E2F1-3 and form a repressor complex. For example, cyclin E was derepressed not only by loss of pRB but also by the combined loss of E2F1-3, suggesting that these E2Fs participate in a repressor complex (Wu et al., 2001) . Cyclin E was also derepressed in cells lacking only E2F3, perhaps reflecting that E2F3b is the main E2F1-3 member that is expressed after mitogen deprivation (Leone et al., 2000; Saavedra et al., 2003) . Moreover, in pRB-deficient cells, the additional loss of E2F4 restored cyclin E repression, while inducing the formation of noncanonical p107-E2F3 and p130-E2F1 complexes (apparently by increasing p107 and p130 availability) . This striking result implies that p107/p130 can substitute for pRB at the cyclin E promoter, but only when available in sufficient quantities to bind E2F1-3.
In summary, a variety of data suggests that pRB may be crucial to the repression of cyclin E due to the specific binding of E2F1-3 to the promoter E2F-Sp1 element, and the preferential binding of pRB to these E2F species. Underlying this model is the more general notion that distinct E2F-pocket protein complexes may be positioned at particular E2F recognition sites through the cooperative interactions of specific E2Fs with other transcription factors. In turn, the unique arrangements of such factors may dictate the distinctive regulatory features of individual E2F-responsive genes.
Pocket protein-mediated repression of cyclin A through HDAC-independent mechanisms
In addition to being regulated by covalent histone modifications, transcription is regulated by nucleosome sliding and assembly processes known as chromatin remodeling (Narlikar et al., 2002) . Pocket proteins may coordinate histone deacetylation with chromatin remodeling by concurrently binding an HDAC complex and a chromatin remodeling machine termed the hSWI/SNF complex . hSWI/SNF complexes contain either the Brahma (Brm) ATPase or the Brmrelated gene product (BRG1) (Narlikar et al., 2002) , both of which may interact with each of the pocket proteins (Dunaief et al., 1994; Strober et al., 1996) .
In keeping with the notion that pocket proteins coordinate histone deacetylation with chromatin remodeling, both HDAC and Brm/BRG1 activities were required for a constitutively active pRB to repress many E2F-responsive genes. However, HDAC activity was dispensable, but Brm/BRG1 were still required, for pRB to repress other genes such as cyclin A, and to induce a cell cycle arrest mediated in part by cyclin A repression (Strobeck et al., 2000; Zhang et al., 2000; SeverChroneos et al., 2001; Siddiqui et al., 2003) . This suggests that pRB may more generally elicit repression through Brm/BRG1 than through HDACs.
pRB may elicit HDAC-independent, but Brm/BRG1-dependent, repression of cyclin A through two mechanisms. In fibroblasts, pRB-mediated repression of cyclin A was associated with an altered chromatin structure at the cyclin A promoter (Siddiqui et al., 2003) . Concordantly, the repression of cyclin A following serum starvation required both pRB and Brm, and was associated with Brm-dependent formation of nucleosomes in the transcription initiation region (Philips et al., 1998; Coisy et al., 2004) . These findings suggest that pRB represses cyclin A through Brm-mediated nucleosome remodeling in fibroblasts.
In another study, p16 was used to induce pocket protein activity in osteosarcoma cells (Dahiya et al., 2001) . Here, the repression of cyclin A was associated with recruitment of Brm to the promoter, consistent with a role for chromatin remodeling in this setting as well. In addition, however, cyclin A repression required the polycomb group protein HPC2, and was accompanied by HPC2 binding to the cyclin A promoter. Overexpression experiments suggested that HPC2 might bind the promoter through a complex of E2F, pRB, and a corepressor called CtBP (Dahiya et al., 2001 (Dahiya et al., , 2003 , although it is unclear whether the endogenous HPC2 is recruited to the promoter in this way.
While the above findings show that Brm is crucial to the repression of cyclin A, further information is needed to understand the HDAC-independent effects of pocket proteins at this promoter. For example, cyclin A repression has not been shown to require direct binding of pRB to Brm, and it remains possible that pocket proteins indirectly engage Brm activity. Moreover, the specific roles of pocket proteins and E2Fs at specific cyclin A promoter sites remain undefined. p107/p130
Pocket proteins and cell cycle control D Cobrinik were needed for cyclin A repression in one series of experiments (Hurford et al., 1997; Rayman et al., 2002) ; pRB was needed in another series (Philips et al., 1998; Coisy et al., 2004) ; and both pRB and the p107/p130 pair were needed in a third analysis (Black et al., 2003) . Perhaps these disparate results reflect the utilization of different pocket proteins and cyclin A repression mechanisms under different experimental conditions. Notably, pocket protein-mediated repression in Drosophila generally did not require HDAC activity (TaylorHarding et al., 2004) . Further study of this system may provide insight into HDAC-independent repression of E2F-responsive genes in mammals, as well as in flies.
Pocket proteins and silencing of E2F-responsive genes
The finding that pRB elicits H3K9 methylation at the cyclin E promoter (Nielsen et al., 2001) has raised the issue of whether this modification is used to repress E2F-responsive genes in a reversible manner, or is only used to silence such genes in cells that have undergone permanent cell cycle exit. Of note, methylated H3K9 has been detected at some promoters that were reversibly repressed (Ghosh and Harter, 2003; Nicolas et al., 2003) , but was detected at higher levels, in some cases in a heterochromatin-like trimethylated state, and associated with HP1, only in irreversibly arrested cells (Narita et al., 2003; Ait-Si-Ali et al., 2004) . On this basis, it appears that pocket protein-mediated methylation of H3K9 may indeed induce silencing of E2F-responsive promoters in some contexts.
One context in which pocket protein-mediated silencing may occur is in cells that are entering senescence. Accordingly, higher levels of methylated H3K9 were detected at the cyclin A and PCNA promoters when human fibroblasts entered senescence versus when they were quiescent. In senescent cells, these promoters also associated with HP1 and were resistant to E2F-mediated activation. Finally, the pocket protein family was required for H3K9 methylation, HP1 recruitment, and promoter silencing (Narita et al., 2003) . These findings suggest that pocket protein-dependent H3K9 methylation, HP1 recruitment, and silencing of E2F-responsive promoters distinguishes senescence from a quiescent state.
Similar results were obtained in an analysis of H3K9 methylation during myoblast differentiation. Upon differentiation, several E2F-responsive genes acquired trimethylated H3K9 in a process that depended upon SUV39H (including SUV39H1 and SUV39H2). This is consistent with the possibility that pocket protein-SUV39H complexes mediate silencing of E2F-responsive genes during cell differentiation (Ait-Si-Ali et al., 2004).
One issue raised by the above findings is whether particular pocket proteins have special roles in mediating H3K9 methylation and transcriptional silencing. In the study by Narita et al. (2003) , pRB was recruited to the cyclin A and PCNA promoters in senescent, but not quiescent, cells. However, p130 bound the promoters under both circumstances, and it is possible that the pRB binding reflected increased expression of pRB or its cognate E2Fs during senescence. Likewise, an E1A mutant that inactivates the entire pocket protein family blocked the silencing of cyclin A, whereas knockdown of only pRB had a comparatively small effect. These findings appear consistent with the notion that each of the pocket proteins can contribute to silencing, in keeping with each of their abilities to bind to SUV39H1 (Nielsen et al., 2001 (Nielsen et al., , 2003 Vandel et al., 2001; Nicolas et al., 2003) . Nonetheless, specific pocket proteins may be required to silence specific promoters in specific settings, depending on the architecture of the promoters and on the relative pocket protein expression levels. A role for pRB in the silencing of cyclin E, perhaps analogous to pRB's role in the repression of cyclin E, could be an instance in which a specific pocket protein is utilized.
Given that pocket proteins mediate both the repression of E2F-responsive genes during quiescence and the silencing of such genes in senescence and differentiation, a major challenge will be to define the contextual signals that dictate whether the 'repression' or the 'silencing' program is engaged. The evidence to date suggests that limited and potentially reversible H3K9 methylation might occur at E2F-regulated promoters during quiescence, whereas more extensive H3K9 methylation and recruitment of HP1 occurs during senescence and differentiation. Thus, contextual cues in cells that are entering senescence or undergoing differentiation may induce the transition between these chromatin states. One aspect that might influence this transition is the identity of the histone methyltransferase that is recruited to a promoter, since p107 was found to bind not only SUV39H1 but also Eu-HMTase1 (Nicolas et al., 2003) . Whereas SUV39H1 is a H3K9 trimethylase that is implicated in transcriptional silencing, Eu-HMTase1 is homologous to the 'G9a' H3K9 mono-and dimethylase (Peters et al., 2003; Rice et al., 2003) and is implicated in reversible promoter repression (Ogawa et al., 2002) .
Pocket protein regulation of the G1-S transition, independent of E2F
While pocket proteins have wide-ranging effects mediated through E2Fs, they also regulate cell cycle transitions through E2F-independent mechanisms. For example, p107 and p130 (but not pRB) bind and inhibit the cyclin E/Cdk2 and cyclin A/Cdk2 kinases (Zhu et al., 1995) . This activity is mechanistically similar to that of the 'Cip/Kip' family of Cdk inhibitors (CKIs), including p21 Cip1 , p27 Kip1 , and p57
Kip2
, and functions redundantly to these CKIs in some contexts. In this regard, p130 was required to inhibit Cdk2 and to prevent S phase entry in mitogen-deprived p27 À/À fibroblasts (Coats et al., 1999) . Similarly, p107 was needed to inhibit Cdk2 and permit mitotic exit in p21 À/À p27 À/À cells that express a stabilized form of cyclin A (Chibazakura et al., 2004) . However, apart from these synthetic effects, a physiological role for the CKI (Laplantine et al., 2002; Rossi et al., 2002) , epidermal cells (Ruiz et al., 2003) , neural stem cells , or cells that have inactivated pRB (see below). More recently, pRB was found to inhibit Cdk activity and G1-S progression by increasing the expression of p27 (Alexander and Hinds, 2001; Ji et al., 2004) . In osteosarcoma cells, pRB rapidly repressed E2F-responsive genes at the RNA level, but induced cell cycle exit well before the protein products of such genes declined (Ji et al., 2004) . In contrast, a pRB-induced increase in p27 preceded, and was required for, cell cycle exit. Mechanistically, pRB stabilized p27 by binding to the F box protein Skp2, interfering with the Skp2-p27 interaction, and inhibiting p27 ubiquitination (Ji et al., 2004) . As p27 has widespread cell cycle effects, its increased expression may be important in many contexts where pRB regulates G1-S progression.
In addition to regulating the G1-S transition through p27, pRB has other E2F-independent functions through which it may inhibit proliferation. For example, pRB can induce the formation of PML nuclear bodies (Fang et al., 2002) , which have widespread effects on cell proliferation, differentiation, and survival (Salomoni and Pandolfi, 2002) . pRB can also suppress Ras signaling (Lee et al., 1999) and augment expression of differentiation-associated genes (Sellers et al., 1998; Thomas et al., 2001) . Additionally, pRB may have E2F-independent effects through interactions with one of the many pRB-binding proteins (Morris and ). The recently-described hLin-9 protein may be particularly relevant, in that it cooperated with pRB to induce a differentiation-related process, and fulfilled a role similar to pRB to suppress transformation, but did not affect the regulation of E2F (Gagrica et al., 2004) .
One context in which the E2F-independent effects of pRB may be important is in the suppression of retinoblastoma. This notion has come from evidence that several 'low-penetrance' pRB mutants retain a partial ability to suppress retinoblastoma despite that they are defective in binding to E2F (Otterson et al., 1997; Harbour, 2001) . Various low penetrance pRB mutants retain abilities to induce p27, to induce PML nuclear bodies, to augment differentiation-associated gene expression, to suppress Ras signaling, and to cooperate with hLin-9 in differentiation (Sellers et al., 1998; Lee et al., 1999; Fang et al., 2002; Ji et al., 2004; Gagrica et al., 2004) , suggesting that one or more of these effects might contribute to retinoblastoma suppression.
Pocket protein regulation of the G0-G1 transition
In addition to regulating the G1-S transition, pocket proteins may regulate the earlier transition from G0 to G1. G0 cells can be distinguished from those in G1 by their diminished RNA content, which reflects diminished production of ribosomal RNAs and tRNAs (Lajtha, 1963; Ladd et al., 1997; Ren and Rollins, 2004) . Pocket proteins may contribute to the G0 state by repressing ribosomal RNA and tRNA gene expression, whereas pocket protein phosphorylation may restore ribosomal RNA and tRNA levels to effect the G0-G1 transition (Cavanaugh et al., 1995; White, 1997; Hannan et al., 2000; Scott et al., 2001) .
In keeping with these considerations, the phosphorylation of pRB by cyclin C-Cdk3 was recently found to increase RNA content while mediating G0 exit (Ren and Rollins, 2004) . Notably, whereas pRB phosphorylation by cyclin C-Cdk3 mediated the G0-G1 transition, it did not supplant the need for the cyclin D-Cdk4/Cdk6 or cyclin E/Cdk2 for progression from G1 into S. Conversely, these 'G1 Cdks' were able to mediate pocket protein phosphorylation during the G0-G1 transition, albeit in a delayed fashion, and seem likely to do so in mouse cells that have a mutant Cdk3 gene (Ye et al., 2001; Ren and Rollins, 2004) .
Pocket proteins and DNA replication y and rereplication
Pocket proteins are known to regulate replication indirectly, by repressing genes that mediate S phase entry as well as genes that encode components of the replication machinery. In addition, after S phase has begun, pRB and possibly p107 can inhibit S phase progression by repressing cyclin A, and thereby inhibiting Cdk2 and PCNA function (Karantza et al., 1993; Kondo et al., 2001; Sever-Chroneos et al., 2001) . These transcriptional effects may be utilized to induce an intra-S phase block in response to DNA damage (Harrington et al., 1998; Knudsen et al., 2000; Kondo et al., 2001; Lan et al., 2002) .
However, studies in Drosophila have shown that pocket proteins can also directly affect replication. These studies showed that the E2F1 and pRB homologs (dE2F1 and Rbf) bind the Drosophila origin recognition complex (DmORC) protein and the chorion gene cluster origin of replication, and thereby limit the physiological amplification of this cluster in ovarian follicle cells (Royzman et al., 1999; Bosco et al., 2001) . dE2F1 and Rbf were also found to suppress genomic rereplication in Drosophila, yet later work indicated that this was mediated through transcriptional effects (Cayirlioglu et al., 2003) . Recent studies suggest that pocket proteins also have replicative functions in vertebrates.
In a surprising development, pocket proteins were found to affect the spatial organization of replication in primary mammalian cells. Initially, pocket proteins and HDACs were found to colocalize with the small number of perinucleolar foci in which replication takes place at the start of S phase. In rapidly proliferating cells, these few foci subsequently redistributed to form hundreds of replication foci that no longer localized with pocket proteins . However, in cells that received antimitogenic signals and were destined for cell cycle exit, the replication foci did not redistribute, and remained associated with pocket proteins throughout Pocket proteins and cell cycle control D Cobrinik S phase. Remarkably, the presence of pRB, p107, and/or p130 was crucial for the production of these focal replication structures (Barbie et al., 2004) . While the function of these structures is not known, they seem to provide pocket proteins the opportunity to modify chromatin concurrent with replication. Thus, they might prepare certain promoters for repression or modify replication origins in cells that are preparing for cell cycle arrest.
pRB is also connected to replication through its role in preventing genomic rereplication. pRB inhibits the spontaneous production of polyploid cells, and suppresses the increased polyploidy that occurs in cells that experience S phase DNA damage, in cells that are blocked at G2/M by ectopically expressed CKIs, and in cells that are blocked in M phase by microtubuleinhibiting drugs (Di Leonardo et al., 1997; Harrington et al., 1998; Niculescu et al., 1998) . Several pRB functions could plausibly account for this capability.
For example, in cells that were irradiated in early S phase, pRB associated with an early firing origin of replication during the S phase block, and then bound to additional replication origins in the order in which they fired. The presence of pRB at origins, at about the time that they replicated, suggested that pRB might modify the origins in a manner that prevents rereplication (Avni et al., 2003) . Notably, pRB's association with late firing replication origins after irradiation is reminiscent of its association with late S phase replication foci in cells that receive antimitogenic signals (Barbie et al., 2004) , suggesting that the two processes may be related.
A second means by which pRB might suppress rereplication could be through effects on the replication licensing machinery, composed of MCM proteins, CDC6, and others. This apparatus binds to replication origins in late M and G1, and prepares -or licensesthem to function after entry into S (Blow and Hodgson, 2002) . Licensing activity is normally suppressed in S, G2, and early M phase by cyclin A-Cdk activity (Yam et al., 2002) . pRB might further suppress relicensing by interacting with MCM7 (Sterner et al., 1998) , or by repressing genes that encode components of the licensing apparatus. In this regard, it is notable that pRB-deficient cells have increased expression of MCM2, 4, 5, 6, and 7 (Black et al., 2003) . pRB-deficient cells also have increased cyclin E, which could further promote relicensing and rereplication (Spruck et al 1999; Coverley et al., 2002) .
Finally, pRB may prevent polyploidy by enforcing the normal expression of mitotic checkpoint proteins such as Emi1 and Mad2. The Emi1 and Mad2 genes are regulated by E2F, and the proteins are overexpressed in pRB-deficient cells or tumors (Hsu et al., 2002; Hernando et al., 2004) . In turn, overexpression of Emi1 or Mad2 delays passage through mitosis, and induces the production of binucleate, aneuploid, and polyploid cells (Margottin-Goguet et al., 2003; Hernando et al., 2004) . Importantly, the overexpression of Mad2 was also required for deregulated E2F to induce aneuploidy and polyploidy (Hernando et al., 2004) , implying that E2F-induced chromosomal defects result from M phase, rather than S phase, abnormalities. Notably, prolongation of the mitotic checkpoint can cause tetraploidy through an 'adaptation' process, in which chromosomes decondense and cells enter a state resembling G1 but with 4N DNA content (Lanni and Jacks, 1998) . From this perspective, polyploidy in pRB-deficient cells may result from increased expression of mitotic checkpoint proteins, a prolonged mitotic block, and then this adaptation response.
New ways to control pocket protein phosphorylation
Cyclin D-Cdk4/Cdk6 and cyclin E-Cdk2 have long been implicated in pocket protein phosphorylation (Weinberg, 1995) . These Cdks have also been suggested to mediate phosphorylation of distinct pRB residues (Mittnacht, 1998) and to inactivate pRB in a step-wise fashion during G1 (Hatakeyama et al., 1994; Lundberg and Weinberg, 1998; Harbour et al., 1999) . However, recent studies challenge these notions, and instead highlight the functional redundancy of the cyclin-Cdk network in pocket protein phosphorylation.
As noted earlier, pRB phosphorylation during the G0-G1 transition appears to be mediated by cyclin CCdk3, but can be mediated by other Cdks in Cdk3-deficient cells (Ren and Rollins, 2004 ). An additional level of redundancy was revealed in finding that D cyclins, E cyclins, and the Cdk4/Cdk6 or Cdk2 kinases were not required for pRB or p107 phosphorylation or for G1-S progression in mouse fibroblasts (Berthet et al., 2003; Geng et al., 2003; Ortega et al., 2003; Kozar et al., 2004; Malumbres et al., 2004) . Concordantly, in cell types that normally require cyclin D1, the misexpression of cyclin E1 was able to substitute for cyclin D1 function . These observations have a number of far reaching implications that are discussed elsewhere (Pagano and Jackson, 2004; Sherr and Roberts, 2004) . However, with regard to pocket proteins, the findings mainly imply that either Cdk4/ Cdk6 or Cdk2 can mediate the phosphorylation events that are needed for S phase entry.
In another unexpected development, pocket proteins have been found to be regulated by kinases other than the canonical cyclin-Cdks. Thus, whereas mitogeninduced pocket protein phosphorylation and release from E2F generally occurs over a period of hours and depends on the induction of cyclin D or cyclin E genes, in several instances this response is far more rapid and occurs through other mechanisms. For example, angiotensin II and serotonin treatment of vascular smooth muscle cells resulted in an ERK-dependent and CDK4-mediated phosphorylation of pRBSer 795 , and pRB dissociation from E2F, within 10 min (Garnovskaya et al., 2004) . Angiotensin II and serotonin are strong mitogens for these cells, suggesting that the phosphorylation initiates cell cycle entry. Also, stimulation of the Fas 'death receptor' elicited pRB phosphorylation and release from E2F within 30 min. Here, pRB appeared to be phosphorylated by p38MAPK on residues distinct from those targeted by Cdks (Wang et al., 1999; Nath Pocket proteins and cell cycle control D Cobrinik et al., 2003) . This p38-dependent pRB phosphorylation resulted in the release of E2F1 and is implicated in Fasinduced apoptosis (Hou et al., 2002) . Conversely, pocket protein dephosphorylation was known to occur in the period from anaphase to G1 and to depend upon protein phosphatase 1 (Ludlow et al., 1993) , but is now also known to occur in other cell cycle phases in response to growth inhibitory signals. For example, protein phosphatase 2A (PP2A) is implicated in producing limited pRB hypophosphorylation in S phase cells and more extensive pRB hypophosphorylation in response to g irradiation (Avni et al., 2003) . Similarly, oxidative stress elicited a rapid PP2A-dependent dephosphorylation of pRB, p107, and p130 (Cicchillitti et al., 2003) , and the differentiation agent all-trans-retinoic acid elicited rapid PP2A-dependent dephosphorylation of p130 (Vuocolo et al., 2003) . Rapid dephosphorylation may also occur in a developmental context. For example, in chondrocytes, FGF induced rapid dephosphorylation of p107, but not p130 or pRB, preceding a p107-dependent G0/G1 arrest (Laplantine et al., 2002; Dailey et al., 2003) .
Whereas pocket protein phosphorylation is often reversed by dephosphorylation, in some situations, phosphorylation may cause permanent inactivation. For example, p130 phosphorylation by Cdk4/Cdk6 permits binding to Skp2, polyubiquitination, and proteasome-mediated degradation in late G1 (Tedesco et al., 2002) . Phosphorylation of pRB may also lead to degradation, but through a different mechanism. Specifically, high levels of Cdk activity may result in phosphorylation of pRB-Ser
567
, and thus destabilization of a pRB intramolecular interaction, exposure of a proteolytic cleavage site, and degradation by an unindentified protease. This phosphorylation-induced degradation of pRB may increase the availability of E2F1 and promote apoptosis in cells that have elevated Cdk activity .
Functional redundancy and compensation among pRB and p107/p130
Whereas pRB and the p107/p130 pair do not regulate E2F-responsive genes in a fully redundant manner (see above), these proteins show considerable redundancy at the cell cycle level. Indeed, fibroblasts lacking either pRB or p107/p130 maintain the ability to arrest in G0/ G1, whereas fibroblasts lacking all three pocket proteins (as well as those lacking only pRB and p107) fail to do so under a variety of circumstances (Dannenberg et al., 2000; Sage et al., 2000) .
Interestingly, in pRB-deficient fibroblasts, the ability to arrest in G0/G1 requires a compensatory increase in p107. The compensatory increase in p107 was delayed after an acute loss of pRB, and this provided an opportunity for further proliferation and immortalization (Sage et al., 2003) . The compensatory increase in p107 also occurs in pRB-deficient human tumor cells and may have a particularly potent antiproliferative effect in cells that have activated Ras (M Classon, personal communication). This might result in a paradoxical increase in tumor suppressor activity following pRB loss, and could account for the general absence of RB mutations, in tumors that have oncogenic Ras signaling.
Currently, the basis for the compensatory antiproliferative effect of p107 is unknown. As one possibility, p107 may partially substitute (though it clearly does not fully substitute) for pRB in the regulation of E2F1-3, and it may thereby repress some E2F-responsive genes that are normally controlled by pRB . Alternatively, the p107 CKI activity may contribute to G0/G1 arrest, perhaps compensating for diminished p27 expression in pRB-deficient cells (Ji et al., 2004) .
Focal deficits in pocket protein redundancy in development and tumorigenesis
Whereas the redundant (or compensatory) actions of pocket proteins can mediate a G0/G1 arrest in pRBdeficient and p107/p130-deficient mouse fibroblasts in vitro, they apparently fail to do so in a number of cell types in vivo. This, in turn, may lead to focal proliferative defects that impede normal development and homeostasis following pRB or p107/p130 loss. For example, pRB-deficient mouse embryos display aberrant proliferation, often with apoptosis and differentiation defects, in fetal liver, lens, brain, muscle, skin, and placenta (reviewed in Liu et al., 2004) . A subset of the apoptotic responses resulted from defective placental function and the ensuing hypoxia (Wu et al., 2003) , but the proliferation and differentiation defects were generally cell autonomous. Additional proliferation and differentiation defects have been observed postnatally in tissue-specific Rb knockouts in the pituitary, lung, cerebellum, retina, prostate, and skin (Vooijs et al., 1998; Marino et al., 2003; Chen et al., 2004; MacPherson et al., 2004; Maddison et al., 2004; Ruiz et al., 2004; Wikenheiser-Brokamp, 2004; Zhang et al., 2004a) . p107 and p130 are needed to control proliferation and differentiation in a more limited spectrum of tissues, including cartilage, epidermis, and brain Ruiz et al., 2003; Vanderluit et al., 2004) .
Currently, the reason why pocket proteins function redundantly in some settings, but fail to do so in others, is unknown. Certain cell types might rely upon particular pocket proteins because the other family members are expressed at low levels or fail to increase, in a compensatory manner, after an initial pocket protein is lost. Alternatively, the affected cell types might require differentiation functions that are uniquely fulfilled by one or another pocket protein, such as pRB-specific functions in osteogenic and myogenic differentiation (Thomas et al., 2001; Huh et al., 2004; Nguyen et al., 2004) and p107/p130-specific functions in chondrocyte differentiation (Laplantine et al., 2002; Rossi et al., 2002) . Defining the roles of specific pocket proteins in different developmental contexts may provide fundamental insight into the underlying differentiation pathways.
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Interestingly, most cell types that exhibit deregulated proliferation in constitutive or tissue-specific Rb and p107/p130 knockouts do not go on to form tumors. Indeed, in Rb þ /À mice, somatic mutagenesis is expected to produce Rb À/À cells in most if not all cell types. However, tumors form only from pituitary and thyroid cells (Williams et al., 1994) . Similarly, RB þ /À humans are expected to generate diverse types of RB À/À cells, yet tumors arise from retinal cells in >90% of such individuals but arise from all other cell types in only B1% of RB þ /À individuals per year (Abramson, 1999) . Thus, in addition to the aberrant proliferation that ensues from the loss of pRB in many cell types, other criteria must be met for tumorigenesis to proceed.
In some settings, the reason why pRB loss results in proliferation but not tumorigenesis may be that p107 fails to compensate for the immediate proliferative effects of pRB loss, but nonetheless provides a 'backup' tumor suppressor effect. This scenario may apply to the mouse retina, in which the loss of pRB elicited deregulated proliferation whereas combined loss of pRB and p107 elicited retinal tumors (RobanusMaandag et al., 1998; Chen et al., 2004; MacPherson et al., 2004; Zhang et al., 2004a, b) . For other cell types that aberrantly proliferate after pRB loss, tumorigenesis may be prevented by p53 (Williams et al., 1994) . For example, loss of pRB in the lung resulted in aberrant proliferation and mild hyperplasia, whereas combined loss of pRB and p53 resulted in small cell lung carcinomas (Meuwissen et al., 2003; WikenheiserBrokamp, 2004) . Presumably, additional genetic and epigenetic changes will be found to complement pocket protein defects in a way that converts aberrantly proliferating cells into tumor cells.
Among the six general criteria that are needed for a normal cell to produce malignant progeny (Hanahan and Weinberg, 2000) , it is important to recognize that the loss of pocket protein function may generally impart only the capacity to ignore antimitogenic signals. Nevertheless, in some contexts, loss of specific pocket proteins may have more pleiotropic effects, potentially relating to their multiple biochemical functions. A potential example of this is in the developing human retina, where loss of pRB is sufficient to initiate the formation of retinoblastoma tumors. This suggests that in the retinoblastoma cell of origin, other pocket proteins do not compensate for the loss of pRB, and p53 and other proteins that normally guard against the effects of pocket protein loss are not effectively engaged. Moreover, the rapid onset of retinoblastoma suggests that the loss of pRB may concurrently fulfill several of the requirements for tumorigenesis, or that the retinoblastoma cell of origin is inclined to fulfill the other requirements within a short time frame, and perhaps with relatively few additional genetic changes. However, we currently have little understanding of the circuitry that underlies this unusual susceptibility. Defining how the loss of pocket protein function coalesces with other gene expression programs to bring about retinoblastoma, as well as other tumors, will constitute a pivotal new chapter in the biology of cancer.
